Back

Long‑acting efficacy of oral stabilized bivalent liposomal iron therapy on iron balance and quality of life in chronic heart failure: more than iron supplementation

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: New analyses and usage of old drugs Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ercole Tagliamonte

Hospital Umberto I, Nocera Inferiore (Italy)

5 More presentations in this session

Presentation thumbnail
Effect of empagliflozin on adenosine triphosphate levels in vivo in patients with type 2 diabetes mellitus combined with heart failure
Miss U. Omurzakova (Bishkek, KG)
Abstract
Presentation thumbnail
Vericiguat and cardiovascular outcomes in heart failure revisited: a bayesian reanalysis of 12,877 patients
Mr P. Batista (BR)
Abstract
Presentation thumbnail
Ambulatory milrinone in advanced heart failure: a single-center comparison of continuous and intermittent infusion strategies
Doctor A. Rioux (Quebec, CA)
Abstract
Presentation thumbnail
Effects of low-dose dapagliflozin on heart failure–related outcomes in patients with heart failure and type 2 diabetes: a subanalysis of the dapper study
Doctor S. Ito (Osaka, JP)
Abstract
Presentation thumbnail
Short‑ and long‑term efficacy of oral stabilized bivalent liposomal iron versus intravenous ferric carboxymaltose in chronic heart failure patients: is there a difference?
Professor E. Tagliamonte (Nocera Inferiore, IT)
Abstract

Access the full session

Session thumbnail
New analyses and usage of old drugs

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy of liposomal bivalent stabilized iron sulfate in improving iron deficiency and quality of life in patients with chronic heart failure: lower costs for better therapy?
1 September 2025
thumbnail
Congress Session
Debate: iron to treat heart failure
11 May 2026
thumbnail
Congress Presentation
Preemptive iron supplementation prevents cardiac iron deficiency and adverse remodelling after myocardial infarction
21 May 2023
thumbnail
Congress Presentation
Iron deficiency testing and prevalence in a Lebanese heart failure population: between guidelines and clinical practice
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources